Gear Up for UnitedHealth (UNH) Q1 Earnings: Wall Street Estimates for Key Metrics

14.04.25 15:15 Uhr

Werte in diesem Artikel
Aktien

516,40 EUR 5,40 EUR 1,06%

Indizes

PKT PKT

40.369,0 PKT -155,8 PKT -0,38%

15.874,6 PKT 232,9 PKT 1,49%

2.615,0 PKT -4,3 PKT -0,16%

5.396,6 PKT -9,3 PKT -0,17%

Analysts on Wall Street project that UnitedHealth Group (UNH) will announce quarterly earnings of $7.27 per share in its forthcoming report, representing an increase of 5.2% year over year. Revenues are projected to reach $111.01 billion, increasing 11.2% from the same quarter last year.The current level reflects an upward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.Given this perspective, it's time to examine the average forecasts of specific UnitedHealth metrics that are routinely monitored and predicted by Wall Street analysts.Analysts expect 'Revenues- Products' to come in at $13.33 billion. The estimate indicates a year-over-year change of +11.9%.The average prediction of analysts places 'Revenues- Services' at $9.76 billion. The estimate suggests a change of +9.8% year over year.According to the collective judgment of analysts, 'Revenues- Premiums' should come in at $86.94 billion. The estimate indicates a year-over-year change of +11.5%.Analysts' assessment points toward 'Revenues- Investment and other income' reaching $1.06 billion. The estimate points to a change of +4.4% from the year-ago quarter.Analysts predict that the 'Operating Statistics - Medical Care Ratio' will reach 85.9%. The estimate is in contrast to the year-ago figure of 84.3%.The combined assessment of analysts suggests that 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Risk-based' will likely reach 9 million. Compared to the current estimate, the company reported 8.55 million in the same quarter of the previous year.The consensus estimate for 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Fee-based' stands at 21.46 million. The estimate compares to the year-ago value of 20.87 million.Based on the collective assessment of analysts, 'UnitedHealthcare Customer Profile - People Served - Total Community and Senior' should arrive at 20.16 million. Compared to the current estimate, the company reported 19.77 million in the same quarter of the previous year.The consensus among analysts is that 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Advantage' will reach 8.21 million. The estimate compares to the year-ago value of 7.76 million.The collective assessment of analysts points to an estimated 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicaid' of 7.62 million. The estimate compares to the year-ago value of 7.68 million.It is projected by analysts that the 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Supplement (Standardized)' will reach 4.33 million. Compared to the current estimate, the company reported 4.33 million in the same quarter of the previous year.Analysts forecast 'UnitedHealthcare Customer Profile - People Served - Medicare Part D stand-alone' to reach 2.81 million. The estimate is in contrast to the year-ago figure of 3.09 million.View all Key Company Metrics for UnitedHealth here>>>UnitedHealth shares have witnessed a change of +22.7% in the past month, in contrast to the Zacks S&P 500 composite's -3.6% move. With a Zacks Rank #2 (Buy), UNH is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf UnitedHealth

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen